A class of FDA-approved cancer drugs may be able to prevent problems with brain cell development associated with disorders including Down syndrome and Fragile X syndrome, researchers have found.
SOURCE: Children’s Health News — ScienceDaily – Read entire story here.
Related Posts
Is HAES a Bunch of Hooey?
- admin
- April 2, 2015
- 0
Health at Every Size is not an organization, but a concept and a movement. There are, however, organizations that promote size tolerance, whether healthy or not. One is the National Association to Advance Fat Acceptance, for which Joanne Ikeda speaks: There has been just study after study showing fat people are discriminated against in housing, employment, college admission, even in adoption. You can today fire a fat person for no other reason other than they are fat, and you don’t want a fat employee. Many deep questions are concealed within those few words. When someone is in a position to hire another person, why shouldn’t they be allowed to have standards? Maybe parents don’t want to hire a smoker as their babysitter. Should they be
Promising research trials find new combination of drugs treat underlying cause of most common form of cystic fibrosis
- admin
- May 17, 2015
- 0
Results from clinical trials show that a new combination of medications can successfully treat the underlying cause of cystic fibrosis for patients 12 and older with two copies of the F508del gene mutation — the most common form of the life-threatening, genetic disease found in over half of the CF population.
Fine particulate air pollution linked to risk of childhood autism
- admin
- May 21, 2015
- 0
Exposure to fine particulate air pollution during pregnancy through the first two years of the child’s life may be associated with an increased risk of a child developing autism spectrum disorder, a condition that affects one in 68 children, according to an investigation of children in southwestern Pennsylvania.